8-K: Final Results of TO


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ______________________________

 FORM 8-K
 ______________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 31, 2013
 ______________________________
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
______________________________
  
Colorado
 
001-35647
 
90-0224471
(State or other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
 
9815 S. Monroe Street, Suite 100, Sandy, UT
 
84070
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (801) 432-9000
______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
 






Item 8.01
Other Events
On October 31, 2013, LifeVantage Corporation (the “Company”) issued a press release announcing the final results of its recently completed tender offer in which the Company offered to purchase for cash up to $40 million in value of shares of its common stock (the "Offer"). A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference.
The foregoing summary of the Offer does not purport to be complete and is qualified in its entirety by reference to the Tender Offer Statement on Schedule TO filed on September 24, 2013, as amended, and such document is incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits.
(d)
Exhibits
Exhibit No.
  
Description
 
99.1
  
Press release issued by the Company on October 31, 2013.







SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: October 31, 2013
LIFEVANTAGE CORPORATION
  
By: /s/ Rob Cutler   
Name: Rob Cutler
Title: General Counsel